IL-Yang Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IL-Yang Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
KolmarBNH Co Ltd
sales of 256.01 billion Korean Won [US$228.87 million]
of which 90%
Samjin Pharmaceutical Company Limited
(239.31 billion Korean Won [US$213.95 million]
of which 100%
was Pharmaceuticals), and
Daewon Pharmaceutical Co Ltd
(240.72 billion Korean Won [US$215.21 million]
of which 99%
IL-Yang Pharmaceutical Company Limited reported sales of 261.61 billion Korean Won (US$233.88 million)
December of 2016.
increase of 5.3%
versus 2015, when the company's sales were 248.38 billion Korean Won.
Sales at IL-Yang Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 89%).